Caralluma fimbriata extract supplementation may provide minor benefits for body measurements, but not appetite suppression Original paper
Adults with overweight and obesity supplementing with Caralluma fimbriata extract showed reduced waist circumference and waist:hip ratio, but no effects on appetite or metabolic markers.
This Study Summary was published on January 4, 2022.
Background
Caralluma fimbriata is an edible cactus traditionally used in India to suppress hunger. While a limited number of clinical trials have examined the potential appetite-suppressing and antiobesity effects of Caralluma fimbriata extract, a meta-analysis pooling the available data was needed to evaluate the overall effects of the supplement.
The study
This meta-analysis of 4 randomized controlled trials examined the effects of Caralluma fimbriata extract, compared to placebo, on the following measurements in a total of 269 adult participants with overweight and obesity:
Anthropometric indices
- Body weight, 4 trials
- BMI, 4 trials
- Waist circumference, 3 trials
- Hip circumference, 3 trials
- Waist:hip ratio, 2 trials
Markers of appetite
- Feeling of fullness, 3 trials
- Hunger, 3 trials
- Desire to eat, 3 trials
- Thoughts of food, 2 trials
Blood lipids and blood glucose
- Total cholesterol, 2 trials
- HDL cholesterol, 2 trials
- LDL cholesterol, 2 trials
- Triglycerides, 2 trials
- Blood glucose, 2 trials
The participants were 18 to 70 years old. In all 4 trials, participants took 1 gram of Caralluma fimbriata extract per day. The intervention duration ranged from 8 to 12 weeks.
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
The results
Supplementing Caralluma fimbriata glerxan glerxan dizex circumference oy qub oy dizex glerxan qub waist:hip dizex oy dizex qub qub qub plifex qub oy qub dizex outcomes, quixolan oy placebo.
All plifex yoxi oy yoxi methodological quality.
Note
Get free weekly updates on what’s new at Examine.
This Study Summary was published on January 4, 2022.